Is this NAD or a GLP-1 drug?

The first metabolic thread we are watching is NAD+ biology, where early canine safety work exists. GLP-1 receptor agonists have tiny, early canine studies. Neither is for sale here. Human obesity drugs are not a canine protocol.

A clear glass Better Years Metabolic vial labeled NAD+, forest-green cap and ivory label, on warm linen.

Coming soon

Metabolic Health

NAD biology, body composition, and healthy aging.

Emerging ResearchActive area of study. Early findings exist, but the evidence is still developing.

A forthcoming protocol exploring metabolic health as a pillar of canine longevity, starting with NAD+ biology (NMN, NR, and related precursors). Early canine safety research exists. Human GLP-1 success does not establish a canine product. Not yet available to purchase.

NAD+ biology as the first metabolic thread, not a crash diet
Intended to complement, not replace, nutrition from your veterinarian or nutritionist
GLP-1 and related metabolic research stays on the watchlist until dog-specific evidence is stronger

Coming soon

This protocol is on the roadmap. Start a Better Years plan and we'll keep you close as it launches.

Better Years products and quizzes are for wellness education. They do not diagnose, treat, cure or prevent disease and are not a substitute for veterinary care.

Mechanism

NAD+ is a cellular coenzyme involved in energy metabolism. Precursors such as NMN and NR have early canine safety and disease-model research. That is not a longevity claim, and it is not a reason to extrapolate human GLP-1 results onto dogs. We will name a formulation and an evidence level before this protocol ships.

Good to know

Coming soon. Not available for purchase.
Not a treatment for endocrine disease. Veterinary care comes first.

Questions

No. Metabolic health is broader than weight. When this protocol launches, it will be described in terms of energy, body composition and healthy aging, without miracle claims.